XML 124 R28.htm IDEA: XBRL DOCUMENT v3.25.4

CAPITAL STOCK (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Equity [Abstract]

SCHEDULE OF SECURITIES PURCHASE AGREEMENT

On April 28, 2024, the Company and the Purchaser entered into an Omnibus Amendment Agreement No. 1, which amended the SPA to, adjust the closings which were to take place under the SPA as follows:

 SCHEDULE OF SECURITIES PURCHASE AGREEMENT

#		Initial Stated Value of Preferred Stock to be issued by installment				Warrants to be issued				Closing Date		Aggregate Purchase Price by installment (USD)
Initial Closing		$	550,000				220,000			Initial Closing Date		$	500,000
Second Closing		$	275,000							On or before June 30, 2024		$	250,000
Third Closing		$	825,000				100,000			On or before June 30, 2024		$	750,000
Fourth Closing		$	1,100,000							Such date as is no later than 180 days after the shares of common stock issuable in respect of the Series B Preferred Stock sold in each of the Initial Closing, Second Closing, the Third Closing, and the Fourth Closing have been registered under the Securities Act, subject to any limitations pursuant to Rule 415		$	1,000,000
Total		$	2,750,000				320,000					$	2,500,000

SCHEDULE OF STOCK OPTION ACTIVITY

The following table summarizes common stock option activity:

 SCHEDULE OF STOCK OPTION ACTIVITY

		Options				Weighted Average Exercise Price
Outstanding, December 31, 2023			176,666			$	10.98
Granted			13,333			$	5.55
Exercised			-				-
Expired / Forfeited			(33,333	)			16.50
Outstanding, December 31, 2024			156,666			$	9.34
Granted			2,000,000			$	2.30
Exercised			-				-
Expired / Forfeited			-				-
Outstanding, September 30, 2025			2,156,666			$	2.81
Exercisable, September 30, 2025			654,444			$	3.94

The following table summarizes common stock option activity:

 SCHEDULE OF STOCK OPTION ACTIVITY

		Options				Weighted Average Exercise Price
Outstanding, December 31, 2022			83,333			$	16.50
Granted			93,333			$	6.05
Exercised			-				-
Expired			-				-
Outstanding, December 31, 2023			176,666			$	10.98
Exercisable, December 31, 2023			120,833			$	8.43
Granted			13,333			$	5.55
Exercised			-				-
Expired / Forfeited			(33,333	)			16.50
Outstanding, December 31, 2024			156,666			$	9.34
Exercisable, December 31, 2024			140,833			$	8.54

SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE

The weighted average exercise prices, remaining lives for options granted, and exercisable as of September 30, 2025 were as follows:

 SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE

				Outstanding Options												Exercisable Options
Options Exercise Price Per Share				Shares				Life (Years)				Weighted Average Exercise Price				Shares				Weighted Average Exercise Price
$	16.50				60,000				2.87			$	16.50				54,167			$	16.50
$	4.80				83,333				3.25			$	4.80				83,333			$	4.80
$	5.55				13,333				1.78			$	5.55				13,333			$	5.55
$	2.30				2,000,000				.99			$	2.30				500,000			$	2.30

The weighted average exercise prices, remaining lives for options granted, and exercisable as of December 31, 2024 were as follows:

 SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE

				Outstanding Options								Exercisable Options
Options Exercise Price Per Share				Shares				Life (Years)				Weighted Average Exercise Price				Shares				Weighted Average Exercise Price
$	16.50				60,000				3.61			$	16.50				44,167			$	16.50
$	4.80				83,333				3.99			$	4.80				83,333			$	4.80
$	5.55				13,333				2.53			$	5.55				13,333			$	5.55

SCHEDULE OF OPTIONS FAIR VALUE ASSUMPTIONS

 SCHEDULE OF OPTIONS FAIR VALUE ASSUMPTIONS

Fair Value of common stock on measurement date		$	31.85 – 4.31
Risk free interest rate			4.13% - 4.10	%
Volatility			142.96% - 136.49	%
Dividend Yield			0	%
Expected Term			5.75 - 3.0

	(1)	The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
	(2)	The trading volatility was determined by calculating the volatility of the Company’s peer group.
	(3)	The Company does not expect to pay a dividend in the foreseeable future.
	(4)	The Company, in accordance with staff accounting bulletin (“SAB”)14-D.2, used the simplified method (plain vanilla) to determine the overall expected term.

 SCHEDULE OF OPTIONS FAIR VALUE ASSUMPTIONS

Fair Value of common stock on measurement date		$	14.90 – 4.33
Risk free interest rate			4.10% - 3.30	%
Volatility			232.05% - 92.54	%
Dividend Yield			0	%
Expected Term			6.0-3.0

	(1)	The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
	(2)	The trading volatility was determined by calculating the volatility of the Company’s peer group.
	(3)	The Company does not expect to pay a dividend in the foreseeable future.
	(4)	The Company, in accordance with staff accounting bulletin (“SAB”)14-D.2, used the simplified method (plain vanilla) to determine the overall expected term.

SCHEDULE OF COMMON STOCK WARRANT ACTIVITY

The following table summarizes common stock warrants activity:

 SCHEDULE OF COMMON STOCK WARRANT ACTIVITY

		Warrants				Weighted Average Exercise Price Per Share
Outstanding, December 31, 2023			89,533			$	16.95
Granted			850,800			$	5.75
Exercised			-				-
Expired			-				-
Cancelled			-				-
Outstanding, December 31, 2024			940,333			$	5.08
Granted			1,482,709			$	1.50
Exercised			1,427,143			$	1.50
Expired			-				-
Cancelled			-				-
Outstanding, September 30, 2025			997,899			$	3.05
Exercisable, September 30, 2025			997,899			$	3.05

The following table summarizes common stock warrants activity:

 SCHEDULE OF COMMON STOCK WARRANT ACTIVITY

		Warrants				Weighted Average Exercise Price Per Share
Outstanding, December 31, 2022			133,333			$	15.00
Granted			24,500				22.14
Exercised			(68,300	)			15.00
Expired			-				-
Cancelled			-				-
Outstanding, December 31, 2023			89,533				16.95
Exercisable, December 31, 2023			89,533				16.95
Granted			850,800				5.75
Exercised			-				-
Expired			-				-
Cancelled			-				-
Outstanding, December 31, 2024			940,333				5.08
Exercisable, December 31, 2024			940,333			$	5.08

SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE

The weighted average exercise prices, remaining lives for warrants granted, and exercisable as of September 30, 2025, were as follows:

 SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE

				Outstanding and Vested Warrants
Weighted Average Warrant Exercise Price Per Share				Shares				Life (Years)
$	3.05				997,899				3.75

The weighted average exercise prices, remaining lives for warrants granted, and exercisable as of December 31, 2024, were as follows:

 SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE

				Outstanding and Vested Warrants
Weighted Average Warrant Exercise Price Per Share				Shares				Life (Years)
$	5.75				940,333				4.46

SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS

 SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS

Fair Value of common stock on measurement date		$	3.12 - $51.12
Risk free interest rate			From 3.82% to 4.59	%
Volatility			From 135.75% to 238.00	%
Dividend Yield			0	%
Expected Term			3 - 5 years

	(1)	The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
	(2)	The trading volatility was determined by calculating the volatility of the Company’s peer group.
	(3)	The Company does not expect to pay a dividend in the foreseeable future.

 SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS

Fair Value of common stock on measurement date		$	3.10 - $10.90
Risk-free interest rate			From 2.95% to 4.38	%
Volatility			From 81.92% to 239.06	%
Dividend Yield			0	%
Expected Term			3 - 5 years

	(1)	The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
	(2)	The trading volatility was determined by calculating the volatility of the Company’s peer group.
	(3)	The Company does not expect to pay a dividend in the foreseeable future.

X

- Definition

Schedule of Shares Purchase Agreement [Table Text Block]

+ References

No definition available.

+ Details

Name:	MGRX_ScheduleOfSharesPurchaseAgreementTableTextBlock
Namespace Prefix:	MGRX_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule of Warrants Plans By Exercise Price Range [Table Text Block]

+ References

No definition available.

+ Details

Name:	MGRX_ScheduleOfWarrantsPlansByExercisePriceRangeTextBlock
Namespace Prefix:	MGRX_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule Of Warrants Valuation Assumptions [Table Text Block]

+ References

No definition available.

+ Details

Name:	MGRX_ScheduleOfWarrantsValuationAssumptionsTableTextBlock
Namespace Prefix:	MGRX_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration